United Therapeutics CEO Executes 17 Rule‑10b5‑1 Trades: $8 Million in Sales, $1.7 Million Purchase in One Day Flash Trade Update.
United Therapeutics insider trades: CEO Benkowitz’s bulk Rule‑10b5‑1 sales and a single purchase reveal liquidity moves, not a confidence shift, while UTHR’s steady pipeline and rising price suggest bullish fundamentals.
5 minutes to read